This autocrine pro-survival mechanism is counterbalanced when cells are treated with recombinant human pro-BDNF, which co-localizes with the complex p75NTR/sortilin, thus inducing and enhancing CRC cell apoptosis15,52. The gene discussed is BDNF; the disease is colorectal carcinoma.